Inhaltsbereich
| 80 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
 Druckansicht
|
| Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging. |
| Ba-Ssalamah A, Antunes C, Feier D, Bastati N, Hodge JC, Stift J, Cipriano MA, Wrba F, Trauner M, Herold CJ, Caseiro-Alves F |
| Radiology. 2015 May 18. doi: 10.1148/radiol.2015142366 |
| PMID: 25985059 |
| Variations in genes involved in dormancy associated with outcome in patients with resected colorectal liver metastases. |
| Stremitzer S, Zhang W, Yang D, Ning Y, Stintzing S, Sunakawa Y, Sebio A, Yamauchi S, Matsusaka S, Parekh A, Barzi A, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz HJ |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 May 8. pii: mdv224. doi: 10.1093/annonc/mdv224. pmc: PMC4511220 |
| PMID: 25957329 |
| Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases. |
| Stremitzer S, Stift J, Singh J, Starlinger P, Gruenberger B, Tamandl D, Gruenberger T |
| European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2015 Mar 24. pii: S0748-7983(15)00335-2. doi: 10.1016/j.ejso.2015.03.223 |
| PMID: 25865557 |
| Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases. |
| Stremitzer S, Sunakawa Y, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Yamauchi S, Matsusaka S, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz HJ |
| The pharmacogenomics journal. 2015 Mar 10. pii: tpj201514. doi: 10.1038/tpj.2015.14 |
| PMID: 25752522 |
| Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases. |
| Stremitzer S, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Sunakawa Y, Yamauchi S, Matsusaka S, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz HJ |
| Cancer. 2015 Feb 17. doi: 10.1002/cncr.29259. pmc: PMC4441595. mid: NIHMS654331 |
| PMID: 25690670 |
| CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases. |
| Stremitzer S, Stift J, Graf A, Singh J, Starlinger P, Gruenberger B, Tamandl D, Gruenberger T |
| Annals of surgical oncology. 2014 Oct 17. doi: 10.1245/s10434-014-4158-8 |
| PMID: 25323471 |
| Response to GEMOX plus erlotinib in pancreatic cancer is associated with ERCC1 overexpression. |
| Fuereder T, Stift J, Kuehrer I, Stranzl N, Hoeflmayer D, Kornek G, Scheithauer W |
| European journal of clinical investigation. 2014 Sep 26. doi: 10.1111/eci.12329 |
| PMID: 25145842 |
| B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer. |
| Meshcheryakova A, Tamandl D, Bajna E, Stift J, Mittlboeck M, Svoboda M, Heiden D, Stremitzer S, Jensen-Jarolim E, Grünberger T, Bergmann M, Mechtcheriakova D |
| PloS one. 2014 Jun 6. doi: 10.1371/journal.pone.0099008. pii: PONE-D-14-04301. pmc: PMC4048213 |
| PMID: 24905750 |
| A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer. |
| Sahora K, Schindl M, Kuehrer I, Eisenhut A, Werba G, Brostjan C, Telek B, Ba'ssalamah A, Stift J, Schoppmann SF, Gnant M |
| Anticancer research. 2014 Apr 29. pii: 34/5/2377 |
| PMID: 24778046 |
| Small bowel adenocarcinoma - terra incognita: A demand for cross-national pooling of data. |
| Schwameis K, Schoppmann SF, Stift J, Schwameis M, Stift A |
| Oncology letters. 2014 Feb 27. doi: 10.3892/ol.2014.1919. pii: ol-07-05-1613. pmc: PMC3997673 |
| PMID: 24765188 |
| Texture-based classification of different gastric tumors at contrast-enhanced CT. |
| Ba-Ssalamah A, Muin D, Schernthaner R, Kulinna-Cosentini C, Bastati N, Stift J, Gore R, Mayerhoefer ME |
| European journal of radiology. 2013 Jul 30. pii: S0720-048X(13)00341-0. doi: 10.1016/j.ejrad.2013.06.024 |
| PMID: 23910996 |
| Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers. |
| Exner R, Pulverer W, Diem M, Spaller L, Woltering L, Schreiber M, Wolf B, Sonntagbauer M, Schröder F, Stift J, Wrba F, Bergmann M, Weinhäusel A, Egger G |
| British journal of cancer. 2015 Sep 3. pii: bjc2015303. doi: 10.1038/bjc.2015.303. pmc: PMC4651135 |
| PMID: 26335606 |
| Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response. |
| Schauer D, Starlinger P, Alidzanovic L, Zajc P, Maier T, Feldman A, Padickakudy R, Buchberger E, Elleder V, Spittler A, Stift J, Pop L, Gruenberger B, Gruenberger T, Brostjan C |
| Oncoimmunology. 2016 Mar 22. doi: 10.1080/2162402X.2016.1160185. pii: 1160185 |
| PMID: 27471631 |
| The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance. |
| Alidzanovic L, Starlinger P, Schauer D, Maier T, Feldman A, Buchberger E, Stift J, Koeck U, Pop L, Gruenberger B, Gruenberger T, Brostjan C |
| Oncotarget. 2016 Aug 5. pii: 11084. doi: 10.18632/oncotarget.11084 |
| PMID: 27527865 |
| Expression of genes involved in vascular morphogenesis and maturation predicts efficacy of bevacizumab-based chemotherapy in patients undergoing liver resection. |
| Stremitzer S, Zhang W, Yang D, Ning Y, Sunakawa Y, Matsusaka S, Parekh A, Okazaki S, Hanna D, Astrow SH, Moran M, Hernandez J, Stephens C, Scherer SJ, Stift J, Wrba F, Gruenberger T, Lenz HJ |
| Molecular cancer therapeutics. 2016 Aug 17. pii: 1535-7163.MCT-16-0275. doi: 10.1158/1535-7163.MCT-16-0275 |
| PMID: 27535973 |
| Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis. |
| Dengler M, Staufer K, Huber H, Stauber R, Bantel H, Weiss KH, Starlinger P, Pock H, Klöters-Plachky P, Gotthardt DN, Rauch P, Lackner C, Stift J, Brostjan C, Gruenberger T, Kumada T, Toyoda H, Tada T, Weiss TS, Trauner M, Mikulits W |
| Oncotarget. 2017 May 3. pii: 17598. doi: 10.18632/oncotarget.17598 |
| PMID: 28526812 |
| Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases. |
| Stift J, Graf A, Schwarz C, Tamandl D, Starlinger P, Herac M, Beer A, Wrba F, Bodingbauer M, Kaczirek K, Stremitzer S |
| European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2017 Nov 26. pii: S0748-7983(17)30980-0. doi: 10.1016/j.ejso.2017.11.018 |
| PMID: 29203074 |
| Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma. |
| Rohr-Udilova N, Klinglmüller F, Schulte-Hermann R, Stift J, Herac M, Salzmann M, Finotello F, Timelthaler G, Oberhuber G, Pinter M, Reiberger T, Jensen-Jarolim E, Eferl R, Trauner M |
| Scientific reports. 2018 Apr 18. doi: 10.1038/s41598-018-24437-5. pii: 10.1038/s41598-018-24437-5 |
| PMID: 29670256 |
| Effect of pathologist's dedication on lymph node detection rate and postoperative survival in colorectal cancer. |
| Unger WL, Muckenhuber M, Stefan R, Argeny S, Stift J, Mesteri I, Stift A |
| Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2018 Apr 28. doi: 10.1111/codi.14241 |
| PMID: 29706021 |
| DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells. |
| Laengle J, Stift J, Bilecz A, Wolf B, Beer A, Hegedus B, Stremitzer S, Starlinger P, Tamandl D, Pils D, Bergmann M |
| Theranostics. 2018 May 10. doi: 10.7150/thno.24699. pii: thnov08p3198. pmc: PMC6010984 |
| PMID: 29930723 |
| 80 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
